These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34577064)

  • 1. Rapid Identification of Potential Drug Candidates from Multi-Million Compounds' Repositories. Combination of 2D Similarity Search with 3D Ligand/Structure Based Methods and In Vitro Screening.
    Szilágyi K; Flachner B; Hajdú I; Szaszkó M; Dobi K; Lőrincz Z; Cseh S; Dormán G
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.
    Dobi K; Flachner B; Pukáncsik M; Máthé E; Bognár M; Szaszkó M; Magyar C; Hajdú I; Lőrincz Z; Simon I; Fülöp F; Cseh S; Dormán G
    Chem Biol Drug Des; 2015 Oct; 86(4):864-80. PubMed ID: 25823681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining 2D and 3D in silico methods for rapid selection of potential PDE5 inhibitors from multimillion compounds' repositories: biological evaluation.
    Tömöri T; Hajdú I; Barna L; Lorincz Z; Cseh S; Dormán G
    Mol Divers; 2012 Feb; 16(1):59-72. PubMed ID: 21947759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 2D/3D ligand-based similarity search in rapid virtual screening from multimillion compound repositories. Selection and biological evaluation of potential PDE4 and PDE5 inhibitors.
    Dobi K; Hajdú I; Flachner B; Fabó G; Szaszkó M; Bognár M; Magyar C; Simon I; Szisz D; Lőrincz Z; Cseh S; Dormán G
    Molecules; 2014 May; 19(6):7008-39. PubMed ID: 24879613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.
    Quintus F; Sperandio O; Grynberg J; Petitjean M; Tuffery P
    BMC Bioinformatics; 2009 Aug; 10():245. PubMed ID: 19671127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of a melanine concentrating hormone receptor-1 (MCHR1) antagonists' focused library and its biological screening with AequoScreen].
    Flachner B; Hajdú I; Dobi K; Lorincz Z; Cseh S; Dormán G
    Acta Pharm Hung; 2013; 83(3):71-87. PubMed ID: 24369586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
    Yoo J; Medina-Franco JL
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches.
    Szilágyi K; Hajdú I; Flachner B; Lőrincz Z; Balczer J; Gál P; Závodszky P; Pirli C; Balogh B; Mándity IM; Cseh S; Dormán G
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31600984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
    Kumar R; Jade D; Gupta D
    J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening.
    Grisoni F; Reker D; Schneider P; Friedrich L; Consonni V; Todeschini R; Koeberle A; Werz O; Schneider G
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27650559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical virtual screening approaches in small molecule drug discovery.
    Kumar A; Zhang KY
    Methods; 2015 Jan; 71():26-37. PubMed ID: 25072167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.
    Vázquez J; López M; Gibert E; Herrero E; Luque FJ
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33076254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
    Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
    PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
    Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein-Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design.
    Kralj S; Jukič M; Bren U
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.